Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
P-glycoprotein (P-gp)
100%
ATP Hydrolysis
94%
Azido
61%
Transition State
42%
Vanadate
38%
Multidrug Resistance
35%
CD4 T Cells
33%
Mechanism of Action
33%
Diphosphate
33%
Highly Active Antiretroviral Therapy (HAART)
33%
Catalytic Cycle
26%
Residual Plasma
26%
Virus
20%
Nucleoside Monophosphates
19%
ATP Site
17%
ATP-binding Cassette Transporter A1 (ABCA1)
15%
Hydrolysis Conditions
14%
Therapy Interruption
13%
Cellular Sources
13%
ADP Release
11%
Conformational Change
11%
ATP Binding
11%
Cancer Cells
7%
ATP Synthase
6%
High Adherence
6%
Compartmental Analysis
6%
Cell-associated Virus
6%
Viral Load Rebound
6%
HIV Quasispecies
6%
Tissue Location
6%
HIV Sequence
6%
Cellular Compartments
6%
Plasma Viral Load
6%
Viral Load
6%
Chronic Infection
6%
Viral Genome
6%
Suppressive Therapy
6%
RNA Copies
6%
Phylogenetic Analysis
6%
Virus Population
6%
Clinical Significance
6%
Patient Plasma
6%
HIV RNA
6%
Cell-derived
6%
Low-level Viremia
6%
Phylogenetic Relationship
6%
Nucleotide-binding Domain
5%
Detailed Chemical Kinetics
5%
Cytotoxic Natural Product
5%
Kinetic Analysis
5%
Biochemistry, Genetics and Molecular Biology
P-Glycoprotein
66%
Adenosine Triphosphate
66%
Enzymatic Hydrolysis
56%
Multidrug Resistance
33%
Adenosine Diphosphate
23%
Pyrophosphate
13%
Nucleoside
13%
Conformation
10%
Conformational Change
6%
ATP-binding Cassette Transporter
6%
ABC Transporter
6%
Nucleotide
6%
Immunology and Microbiology
Human Immunodeficiency Virus
33%
P-Glycoprotein
33%
Blood Plasma
33%
T-Helper Cell
33%
Blood Level
33%
Virus
13%
Viral Load
10%
Rebound
6%
Tumor Cell
6%
Multidrug Resistance Protein 1
6%
